Cyprotex Highlights - January 2022
From March 27-31, 2022, Cyprotex, together with parent company, Evotec, will be exhibiting at the 61st Annual Society of Toxicology Meeting (SOT) in San Diego. At this in-person event you can find us at booth number 1226.
Our panel of experts will be on hand to discuss your project and keep you up-to-date on our latest research. Get in touch to meet us at SOT:
We also have a full schedule of presentations and posters to share with you over the course of the event including an exhibitor hosted seminar presented by Paul Walker, PhD. Find out more using the link below:
Our latest blog, “Trends and Future Outlook in the Early Prediction of Neurotoxicity”, provides an overview of a recent webinar presented by Chris Strock, PhD, also now available to watch on demand.
Read the latest news from parent company, Evotec:
- Evotec receives US$ 18 m grant to accelerate progress in the area of women’s health and contraceptive technology
- Evotec receives € 7.5 m grant for development of a therapeutic against COVID-19
- Evotec expands neuroscience collaboration with Bristol Myers Squibb to tackle neurodegenerative diseases including Alzheimer’s through a novel approach to targeted protein degradation
- Evotec partner Celmatix achieves third milestone for PCOS drug programme in 5 year multi-target alliance with Evotec
- Evotec and Lilly enter into drug discovery collaboration in metabolic diseases with a focus on kidney diseases and diabetes
- Evotec and Boehringer Ingelheim enter drug discovery partnership to tackle vision-related diseases
Read more from Evotec, Cyprotex and Just - Evotec Biologics in the Science Pool blog:
.jpeg)
Telephone:
Europe: +44 (0)1625 505100
North America (East Coast): +1-888-297-7683
Email:
enquiries@cyprotex.com